×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO Asia Virtual Congress 2020
Final Programme PDF
Advanced Search
20.11.2020
21.11.2020
22.11.2020
Collaborative session
Educational session
Industry Satellite Symposium
Mini Oral session
Opening session
Poster Display
Special Session
Young Oncologist session
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
Channel 1
17:10(1h 20m)
Are large NGS panels really changing patient outcomes?
12:00(1h 30m)
AstraZeneca - Improving outcomes with immuno-oncology: Evolving treatment paradigms for first-line ES-SCLC and unresectable Stage III NSCLC
14:00(1h 20m)
Challenges for molecularly-driven diseases in 2020
20:30(1h 30m)
Joint SITC-ESMO Immunotherapy Primer 1
18:45(1h 15m)
Mini oral session on Gastrointestinal tumours 1
11:00(45m)
Opening session and Keynote address - Beyond immune checkpoint blockade: Emerging strategies
15:35(1h 20m)
What are the most exciting new developments in immunotherapy of cancer?
Channel 2
14:00(1h 20m)
Biomarkers in the management of colorectal cancer
12:00(1h 30m)
Bristol Myers Squibb - The role of immuno-oncology in the evolving treatment landscapes of upper GI cancers
17:10(1h 20m)
Genetic testing for hereditary breast cancer and therapeutic implications
18:45(1h 35m)
Mini oral session on Breast cancer
15:35(1h 20m)
Optimal treatment of prostate cancer in changing times
Channel 3
18:45(1h 20m)
Mini oral session on Thoracic cancers
12:00(1h 30m)
MSD - Extending Longer-Term Survival in Lung Cancer and HNSCC with IO and Novel Combinations
15:35(1h 20m)
Precision oncology: Genomics and beyond
17:10(1h 20m)
Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice
14:00(1h 20m)
Therapeutic decisions in the adjuvant setting of melanoma
Channel 4
12:00(1h 30m)
Daiichi Sankyo - Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)
15:35(1h 20m)
Gastric cancer in Asia Pacific and the West (in collaboration with JSMO)
17:10(1h 20m)
Innovation in oncology drug development and regulation (in collaboration with CSCO)
18:45(1h 35m)
Mini oral session on Developmental and precision medicine
14:00(1h 20m)
Optimizing health care systems: Sustainability, accessibility, excellence (in collaboration with KSMO)
Channel 5
15:35(1h 20m)
Cancer policy in the Asia-Pacific region: How to successfully advocate for access to care and research
18:45(1h 15m)
Clinical cases discussion 1
14:00(1h 20m)
Contemporary combination strategies of radiotherapy in the multidisciplinary management of advanced cancers
17:10(1h 20m)
Hopes and limitations for CRISPR technology in cancer (in collaboration with AACR)
12:00(1h 30m)
Pfizer - Clinical Evidence to Real-World Experience: Bridging the Best of Both Worlds in the Management of ER+ HER2- mBC
Channel 6
12:00(1h 30m)
Merck Pfizer Alliance - New developments in mUC and mRCC: The year 2020 in review
On-Demand e-Poster Display
09:00(11h)
e-Poster Display Session
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events